2 studies on Dopamine d2 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
These findings underscore OEA's potential as a novel therapeutic agent for Alcohol Use Disorder, targeting multiple pathways involved in addiction neurobiology and peripheral organ damage. By modulating both central n…
This research provides compelling evidence that GLP-1 receptor agonists could represent a novel and effective strategy for smoking cessation. The observed reductions in nicotine seeking and withdrawal symptoms, couple…